MICROBOT MEDICAL INC. Cash and Cash Equivalents, Period Increase (Decrease)
MICROBOT MEDICAL INC. (MBOT) reported Cash and Cash Equivalents, Period Increase (Decrease) of $8.08 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-04-02
- MICROBOT MEDICAL INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$942.00K, a 144.12% decline year-over-year.
- MICROBOT MEDICAL INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$1.35M.
- MICROBOT MEDICAL INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $8.08M, a 1058.68% increase year-over-year.
- MICROBOT MEDICAL INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $2.29M.
- MICROBOT MEDICAL INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $8.08M, a 255.55% increase from fiscal 2016.
- MICROBOT MEDICAL INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $2.27M.
- MICROBOT MEDICAL INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$354.00K.
- MICROBOT MEDICAL INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$5.58M, a 125.24% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$942.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$2.29M derived: sum of 2 quarters · filed 2018-04-02 | $5.79M derived: sum of 3 quarters · filed 2018-04-02 | $8.08M 10-K · filed 2018-04-02 |
| 2017-09-30 | -$1.35M 10-Q · filed 2017-11-14 | $6.73M derived: sum of 2 quarters · filed 2017-11-14 | $9.02M 10-Q · filed 2017-11-14 | $11.15M derived: sum of 4 quarters · filed 2018-04-02 |
| 2017-06-30 | $8.08M 10-Q · filed 2017-08-14 | $10.37M 10-Q · filed 2017-08-14 | $12.50M derived: sum of 3 quarters · filed 2018-04-02 | $12.24M derived: sum of 4 quarters · filed 2018-04-02 |
| 2017-03-31 | $2.29M 10-Q · filed 2017-05-15 | $4.43M derived: sum of 2 quarters · filed 2018-04-02 | $4.16M derived: sum of 3 quarters · filed 2018-04-02 | $4.86M derived: sum of 4 quarters · filed 2018-04-02 |
| 2016-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $1.87M derived: sum of 2 quarters · filed 2018-04-02 | $2.56M derived: sum of 3 quarters · filed 2018-04-02 | $2.27M 10-K · filed 2018-04-02 |
| 2016-09-30 | -$267.00K 10-Q · filed 2017-11-14 | $430.00K derived: sum of 2 quarters · filed 2017-11-14 | $137.00K 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $697.00K 10-Q · filed 2017-08-14 | $404.00K 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | -$293.00K 10-Q · filed 2017-05-15 | |||
| 2015-12-31 | -$354.00K 10-K · filed 2017-03-21 | |||
| 2015-06-30 | $15.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $4.96M 10-Q · filed 2015-08-06 | -$2.26M derived: sum of 3 quarters · filed 2015-08-06 | $12.12M derived: sum of 4 quarters · filed 2015-08-06 |
| 2015-03-31 | -$10.81M 10-Q · filed 2015-05-05 | -$18.02M derived: sum of 2 quarters · filed 2015-05-05 | -$3.65M derived: sum of 3 quarters · filed 2015-05-05 | -$12.27M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-12-31 | -$7.21M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $7.16M derived: sum of 2 quarters · filed 2015-03-13 | -$1.46M derived: sum of 3 quarters · filed 2015-08-06 | -$5.58M 10-K · filed 2015-03-13 |
| 2014-09-30 | $14.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $5.76M derived: sum of 2 quarters · filed 2015-08-06 | $1.63M 10-Q · filed 2014-11-13 | $11.26M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-06-30 | -$8.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$12.74M 10-Q · filed 2015-08-06 | -$3.11M derived: sum of 3 quarters · filed 2015-08-06 | -$4.91M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | -$4.12M 10-Q · filed 2015-05-05 | $5.51M derived: sum of 2 quarters · filed 2015-05-05 | $3.71M derived: sum of 3 quarters · filed 2015-05-05 | $19.23M derived: sum of 4 quarters · filed 2015-05-05 |
| 2013-12-31 | $9.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $7.83M derived: sum of 2 quarters · filed 2015-03-13 | $23.35M derived: sum of 3 quarters · filed 2015-03-13 | $22.12M 10-K · filed 2015-03-13 |
| 2013-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $13.72M derived: sum of 2 quarters · filed 2014-11-13 | $12.49M 10-Q · filed 2014-11-13 | $5.25M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $15.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $14.29M 10-Q · filed 2014-08-12 | $7.05M derived: sum of 3 quarters · filed 2015-03-13 | $15.56M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | -$1.23M 10-Q · filed 2014-05-14 | -$8.47M derived: sum of 2 quarters · filed 2015-03-13 | $37.97K derived: sum of 3 quarters · filed 2015-03-13 | -$2.21M derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | -$7.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.27M derived: sum of 2 quarters · filed 2015-03-13 | -$975.59K derived: sum of 3 quarters · filed 2015-03-13 | -$4.82M 10-K · filed 2015-03-13 |
| 2012-09-30 | $8.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $6.26M derived: sum of 2 quarters · filed 2013-11-05 | $2.41M 10-Q · filed 2013-11-05 | $8.43M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | -$2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$6.10M 10-Q · filed 2013-08-07 | -$74.52K derived: sum of 3 quarters · filed 2014-03-13 | $711.19K derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | -$3.85M 10-Q · filed 2013-05-10 | $2.17M derived: sum of 2 quarters · filed 2014-03-13 | $2.96M derived: sum of 3 quarters · filed 2014-03-13 | -$3.56M derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $6.02M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $6.81M derived: sum of 2 quarters · filed 2014-03-13 | $288.30K derived: sum of 3 quarters · filed 2014-03-13 | -$6.35M 10-K · filed 2014-03-13 |
| 2011-09-30 | $785.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$5.73M derived: sum of 2 quarters · filed 2012-11-08 | -$12.37M 10-Q · filed 2012-11-08 | -$17.19M derived: sum of 4 quarters · filed 2013-03-21 |
| 2011-06-30 | -$6.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$13.16M 10-Q · filed 2012-08-08 | -$17.97M derived: sum of 3 quarters · filed 2013-03-21 | -$24.20M derived: sum of 4 quarters · filed 2013-03-21 |
| 2011-03-31 | -$6.64M 10-Q · filed 2012-05-10 | -$11.45M derived: sum of 2 quarters · filed 2013-03-21 | -$17.69M derived: sum of 3 quarters · filed 2013-03-21 | |
| 2010-12-31 | -$4.82M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | -$11.05M derived: sum of 2 quarters · filed 2013-03-21 | -$18.86M 10-K · filed 2013-03-21 | |
| 2010-09-30 | -$6.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$14.04M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$7.81M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $8.84M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |